Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DocCheck AG Board/Management Information 2002

Jun 27, 2002

4574_rns_2002-06-27_3cf611a8-e348-4a27-afd3-590f6e93ca74.html

Board/Management Information

Open in viewer

Opens in your device viewer

News Details

Ad-hoc | 27 June 2002 20:35

antwerpes AG english

Supervisory board change for antwerpes ag Ad-hoc-announcement transmitted by DGAP. The issuer is solely responsible for the content of this announcement. ——————————————————————————– Supervisory board change for antwerpes ag Cologne, 27 June 2002 – The chairman of the supervisory board of antwerpes ag (ISIN DE0005471007 // WKN 547100), PD Dr. Dr. Christian Dierks, will be standing down by mutual agreement with the management board as of 31 July 2002. In future Dr. Dierks will concentrate on developing the basic legal conditions for telemedicine and taking on new responsibilities for the action forum for telematics in the health service (Aktionsforum Telematik im Gesundheitswesen, ATG), and the European Health Telematics Association (EHTEL). Dr. Dierks has been chairman of the supervisory board of antwerpes & partner ag and of antwerpes ag since 1998. The management board would like to take this opportunity to thank him for his close cooperation in recent years. Dr. Dierks will continue to be involved in consultancy projects for antwerpes ag. The management board of antwerpes ag has succeeded in gaining Michael Thiess as a new member of the supervisory board. Mr Thiess has been a member of antwerpes ag’s advisory board since last year. He will vacate this post upon moving to the supervisory board. Mr Thiess holds a master degree in psychology and business administration. He worked for the consultancy firm Roland Berger Strategy Consultants from 1989 to 2002, over ten years of which as a partner. His main focus was on consultancy projects for major international companies in the pharmaceutical industry and medical technology, as well as in the healthcare sector. The management board will apply to Cologne district court to appoint Mr Thiess to the supervisory board. The supervisory board will then elect one of its members as the new chairman. The appointment to the supervisory board will be effective until the next ordinary general meeting, where it will be decided whether Mr Thiess should continue to be a member of the supervisory board. Contact: antwerpes ag, Tanja Mumme, Corporate Communications, Vogelsanger Str. 66, D- 50823 Cologne, fon: +49-221-92053-139; fax: +49-221-92053-133, eMail: [email protected] end of ad-hoc-announcement (c)DGAP 27.06.2002 ——————————————————————————– WKN: 547100; ISIN: DE0005471007; Index: Listed: Neuer Markt in Frankfurt; Freiverkehr in Berlin, Bremen, Düsseldorf, Hamburg, München, Hannover und Stuttgart 272035 Jun 02